000 | 01952 a2200565 4500 | ||
---|---|---|---|
005 | 20250517080751.0 | ||
264 | 0 | _c20170109 | |
008 | 201701s 0 0 eng d | ||
022 | _a1365-4632 | ||
024 | 7 |
_a10.1111/ijd.13236 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStrober, Bruce | |
245 | 0 | 0 |
_aSecukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials. _h[electronic resource] |
260 |
_bInternational journal of dermatology _cApr 2016 |
||
300 |
_a401-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPain _xetiology |
650 | 0 | 4 | _aPatient Reported Outcome Measures |
650 | 0 | 4 |
_aPruritus _xetiology |
650 | 0 | 4 |
_aPsoriasis _xcomplications |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aSymptom Assessment |
700 | 1 | _aSigurgeirsson, Bárður | |
700 | 1 | _aPopp, Georg | |
700 | 1 | _aSinclair, Rodney | |
700 | 1 | _aKrell, James | |
700 | 1 | _aStonkus, Sigitas | |
700 | 1 | _aSepte, Marcis | |
700 | 1 | _aElewski, Boni E | |
700 | 1 | _aGottlieb, Alice B | |
700 | 1 | _aZhao, Yang | |
700 | 1 | _aTran, Mary H | |
700 | 1 | _aKarpov, Alexander | |
700 | 1 | _aMcLeod, Lori D | |
700 | 1 | _aMordin, Margaret | |
700 | 1 | _aPapavassilis, Charis | |
700 | 1 | _aNyirady, Judit | |
700 | 1 | _aLebwohl, Mark | |
773 | 0 |
_tInternational journal of dermatology _gvol. 55 _gno. 4 _gp. 401-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/ijd.13236 _zAvailable from publisher's website |
999 |
_c25722937 _d25722937 |